Cargando…
TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA(A) receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia
GABAergic drugs are of interest for the treatment of anxiety, depression, bipolar disorder, pain, cognitive impairment associated with schizophrenia (CIAS), and other neuropsychiatric disorders. Some evidence suggests that TPA-023, (7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2...
Autores principales: | Rajagopal, Lakshmi, Huang, Mei, Michael, Eric, Kwon, Sunoh, Meltzer, Herbert Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180114/ https://www.ncbi.nlm.nih.gov/pubmed/30093697 http://dx.doi.org/10.1038/s41386-018-0160-3 |
Ejemplares similares
-
PM430. Blonanserin reversed phencyclidine-induced novel object recognition deficit and induced cortical dopamine and acetylcholine efflux through dopamine D(3) receptor antagonism
por: Miyauchi, Masanori, et al.
Publicado: (2016) -
Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats
por: Young, A.M.J., et al.
Publicado: (2015) -
Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition
por: Xiao, Xiaolin, et al.
Publicado: (2011) -
Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia
por: Asif-Malik, Aman, et al.
Publicado: (2017) -
Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia
por: Tsivion-Visbord, Hadas, et al.
Publicado: (2020)